Ohcanbohtosat - Gee‐Chen Chang
- Čájehuvvo 1 - 20 / 49
- Sirdás čuovvovaš siidui
-
1
Genetic Polymorphism of XRCC1 Arg399Gln Is Associated With Survival in Non–Small-Cell Lung Cancer Patients Treated With Gemcitabine/Platinum Dahkki Wei‐Yu Liao, Jin‐Yuan Shih, Gee‐Chen Chang, Yu-Kai Cheng, James Chih‐Hsin Yang, Yuh‐Min Chen, Chong‐Jen Yu
Almmustuhtton 2012Artigo -
2
Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer Dahkki Sheng-Yi Lin, Hsiu-Hui Chang, Yi-Hua Lai, Ching‐Hsiung Lin, Min-Hsuan Chen, Gee‐Chen Chang, Meng-Feng Tsai, Jeremy J.W. Chen
Almmustuhtton 2015Artigo -
3
Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy Dahkki Jen‐Yi Lee, Yee-Ming Lee, Gee‐Chen Chang, Sung‐Liang Yu, Wan-Yu Hsieh, Jeremy J.W. Chen, Huei‐Wen Chen, Pan‐Chyr Yang
Almmustuhtton 2011Artigo -
4
P2.14-59 Osimertinib in EGFR T790M Advanced NSCLC: Analysis of Uncommon/Complex EGFR Mutations in a Real-World Study (ASTRIS) Dahkki Parneet Cheema, Antonio Passaro, Charles E. Martin, Marcello Tiseo, K. Park, Gee‐Chen Chang, Yang Hu, Byoung Chul Cho, Margarida S. Miranda, A. Fernandes, H. Freitas
Almmustuhtton 2019Artigo -
5
-
6
-
7
PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients Dahkki Kuo-Hsuan Hsu, Jeng‐Sen Tseng, Tsung‐Ying Yang, Kun‐Chieh Chen, Kang‐Yi Su, Sung‐Liang Yu, Jeremy J.W. Chen, Yen-Hsiang Huang, Gee‐Chen Chang
Almmustuhtton 2022Artigo -
8
Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer In Vitro and In Vivo Dahkki Chieh‐Shan Wu, Yun‐Ju Chen, Jeremy J.W. Chen, Jeng‐Jer Shieh, Chia-Hsin Huang, Pei-Shan Lin, Gee‐Chen Chang, JingHua-Tsai Chang, Chi‐Chen Lin
Almmustuhtton 2011Artigo -
9
The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer Dahkki Ming‐Fang Wu, Chih-An Lin, Tzu‐Hang Yuan, Hsiang‐Yuan Yeh, Sheng‐Fang Su, Chin‐Lin Guo, Gee‐Chen Chang, Ker-Chau Li, Chao‐Chi Ho, Huei‐Wen Chen
Almmustuhtton 2020Artigo -
10
The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma Dahkki Pei-Fang Hung, Tse‐Ming Hong, Yi‐Chiung Hsu, Hsuan‐Yu Chen, Yih‐Leong Chang, Chen‐Tu Wu, Gee‐Chen Chang, Yuh‐Shan Jou, Szu‐Hua Pan, Pan‐Chyr Yang
Almmustuhtton 2013Artigo -
11
A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma Dahkki Tony Mok, Sarayut Lucien Geater, Wu‐Chou Su, Eng-Huat Tan, James Chih‐Hsin Yang, Gee‐Chen Chang, May Han, Philip Komarnitsky, Francis Payumo, Jennifer Garrus, Sandra Close, Keunchil Park
Almmustuhtton 2016Artigo -
12
Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma Dahkki Jeng‐Sen Tseng, Tsung‐Ying Yang, Chi‐Ren Tsai, Kun‐Chieh Chen, Kuo-Hsuan Hsu, Meen-Hsin Tsai, Sung‐Liang Yu, Kang‐Yi Su, Jeremy J.W. Chen, Gee‐Chen Chang
Almmustuhtton 2014Artigo -
13
Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target Dahkki Kuan-Chung Hsiao, Neng-Yao Shih, Hsun-Lang Fang, Tze‐Sing Huang, Ching-Chuan Kuo, Pei‐Yi Chu, Yi‐Mei Hung, Shao-Wen Chou, Yi-Yuan Yang, Gee‐Chen Chang, Ko-Jiunn Liu
Almmustuhtton 2013Artigo -
14
Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program Dahkki Solange Peters, Alessandra Curioni‐Fontecedro, Hovav Nechushtan, Jin‐Yuan Shih, Wei‐Yu Liao, Oliver Gautschi, Vito Spataro, Mojca Unk, James Chih‐Hsin Yang, Robert M. Lorence, Philippe Carrière, A. Cseh, Gee‐Chen Chang
Almmustuhtton 2018Artigo -
15
MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC Dahkki Yi‐Long Wu, Byoung Chul Cho, Qing Zhou, Gee‐Chen Chang, Liyan Jiang, Giulio Metro, Claudio Martín, Gilberto de Castro, Johan Vansteenkiste, David Vicente, A. Milner, James R. Rigas, Y. Chen, Mariano Provencio
Almmustuhtton 2018Artigo -
16
Pretreatment Epidermal Growth Factor Receptor (<i>EGFR</i>) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Ca... Dahkki Kang‐Yi Su, Hsuan‐Yu Chen, Ker-Chau Li, Min‐Liang Kuo, James Chih‐Hsin Yang, Wing‐Kai Chan, Bing‐Ching Ho, Gee‐Chen Chang, Jin‐Yuan Shih, Sung‐Liang Yu, Pan‐Chyr Yang
Almmustuhtton 2012Artigo -
17
HOXA5 Inhibits Metastasis via Regulating Cytoskeletal Remodelling and Associates with Prolonged Survival in Non-Small-Cell Lung Carcinoma Dahkki Chi-Chung Wang, Kang‐Yi Su, Hsuan‐Yu Chen, So-Yi Chang, Chi-Fan Shen, Chia-Hung Hsieh, Qi-Sheng Hong, Ching-Cheng Chiang, Gee‐Chen Chang, Sung‐Liang Yu, Jeremy J.W. Chen
Almmustuhtton 2015Artigo -
18
The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarc... Dahkki Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng‐Sen Tseng, Kun‐Chieh Chen, Chia-Hung Hsu, Kang‐Yi Su, Jeremy J.W. Chen, Huei‐Wen Chen, Sung‐Liang Yu, Tsung‐Ying Yang, Gee‐Chen Chang
Almmustuhtton 2018Artigo -
19
Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report Dahkki James Chih‐Hsin Yang, Frances A. Shepherd, Dong‐Wan Kim, Gyeong‐Won Lee, Jong Seok Lee, Gee‐Chen Chang, Sung Sook Lee, Yu‐Feng Wei, Yun Gyoo Lee, Gianluca Laus, Barbara Collins, Francesca Pisetzky, Leora Horn
Almmustuhtton 2019Artigo -
20
Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis Dahkki Pei-Fang Hung, Tse‐Ming Hong, Che‐Chang Chang, Chung‐Lieh Hung, Yuan-Ling Hsu, Yih‐Leong Chang, Chen‐Tu Wu, Gee‐Chen Chang, Nei‐Li Chan, Sung‐Liang Yu, Pan‐Chyr Yang, Szu‐Hua Pan
Almmustuhtton 2019Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Cancer
Internal medicine
Biology
Lung cancer
Oncology
Genetics
Gene
Cancer research
Epidermal growth factor receptor
Adenocarcinoma
Gefitinib
Gastroenterology
Biochemistry
Confidence interval
T790M
Erlotinib
Genotype
Single-nucleotide polymorphism
Pathology
Genome-wide association study
Osimertinib
Cell biology
Genetic association
Metastasis
Adverse effect
Environmental health
Bioinformatics
Chemotherapy
Clinical endpoint